MA44384A - Formulation d'amidon de pois d'acide polyinosinique-polycytidylique (poly(i:c)) pour la prévention et/ou le traitement d'infections des voies respiratoires supérieures - Google Patents

Formulation d'amidon de pois d'acide polyinosinique-polycytidylique (poly(i:c)) pour la prévention et/ou le traitement d'infections des voies respiratoires supérieures

Info

Publication number
MA44384A
MA44384A MA044384A MA44384A MA44384A MA 44384 A MA44384 A MA 44384A MA 044384 A MA044384 A MA 044384A MA 44384 A MA44384 A MA 44384A MA 44384 A MA44384 A MA 44384A
Authority
MA
Morocco
Prior art keywords
polyinosinic
poly
prevention
treatment
respiratory tract
Prior art date
Application number
MA044384A
Other languages
English (en)
French (fr)
Inventor
Jurgen Mensch
Dijck Alex Henri Van
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MA44384A publication Critical patent/MA44384A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA044384A 2015-05-11 2016-05-10 Formulation d'amidon de pois d'acide polyinosinique-polycytidylique (poly(i:c)) pour la prévention et/ou le traitement d'infections des voies respiratoires supérieures MA44384A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15167129 2015-05-11

Publications (1)

Publication Number Publication Date
MA44384A true MA44384A (fr) 2019-01-23

Family

ID=53174864

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044384A MA44384A (fr) 2015-05-11 2016-05-10 Formulation d'amidon de pois d'acide polyinosinique-polycytidylique (poly(i:c)) pour la prévention et/ou le traitement d'infections des voies respiratoires supérieures

Country Status (12)

Country Link
US (1) US20180353533A1 (enExample)
EP (1) EP3294268A1 (enExample)
JP (1) JP2018515530A (enExample)
KR (1) KR20180004233A (enExample)
CN (1) CN107820423A (enExample)
AU (1) AU2016259869A1 (enExample)
CA (1) CA2983659A1 (enExample)
HK (1) HK1251926A1 (enExample)
MA (1) MA44384A (enExample)
RU (1) RU2017142710A (enExample)
TW (1) TW201705963A (enExample)
WO (1) WO2016181226A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824896A4 (en) * 2018-07-20 2022-08-24 Shiseido Company, Ltd. VIRUS INACTIVATION AGENT
CU20200110A7 (es) * 2020-12-23 2022-08-09 Ct Ingenieria Genetica Biotecnologia Péptidos para el tratamiento de infecciones respiratorias de origen viral
KR102451861B1 (ko) 2021-03-09 2022-10-07 주식회사 오라팜 급성 호흡기 바이러스 및 로타바이러스 감염 질환 예방 및 치료를 위한 조성물
KR102439760B1 (ko) 2021-03-09 2022-09-02 주식회사 오라팜 상기도 감염균 질환 예방 및 치료를 위한 조성물
CN114917242A (zh) * 2022-05-31 2022-08-19 复旦大学附属中山医院 合成双链rna类似物经滴鼻预防呼吸道传播病毒的应用及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
CN101229378A (zh) * 2005-05-05 2008-07-30 国家淀粉及化学投资控股公司 用于送递活性剂的组合物
JP2009209086A (ja) * 2008-03-04 2009-09-17 Masami Moriyama 粘膜投与型ワクチン
CN101757018A (zh) * 2008-12-24 2010-06-30 天津瑞普生物技术股份有限公司 一种用于畜禽的聚肌胞干粉及其制备方法
CN102988303A (zh) * 2011-09-15 2013-03-27 天津泽世德生物医药有限公司 一种多聚肌苷酸多聚胞苷酸冻干粉针的制备方法
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
TWI643082B (zh) * 2013-09-03 2018-12-01 美商新思科技股份有限公司 一種佈線出一解決路徑之方法及系統
KR20160072140A (ko) * 2013-11-06 2016-06-22 얀센 사이언시즈 아일랜드 유씨 상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형

Also Published As

Publication number Publication date
KR20180004233A (ko) 2018-01-10
HK1251926A1 (zh) 2019-05-03
US20180353533A1 (en) 2018-12-13
WO2016181226A1 (en) 2016-11-17
CN107820423A (zh) 2018-03-20
CA2983659A1 (en) 2016-11-17
EP3294268A1 (en) 2018-03-21
TW201705963A (zh) 2017-02-16
RU2017142710A (ru) 2019-06-11
JP2018515530A (ja) 2018-06-14
AU2016259869A1 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
FR22C1063I2 (fr) Composés thérapeutiques utiles pour le traitement prophylactique ou thérapeutique d'une infection par le virus du vih
FR25C1042I1 (fr) Composition pharmaceutique pour la prévention et/ou le traitement de la dermatite atopique contenant comme principe actif un antagoniste de l'il-31
EP3533466A4 (en) PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND / OR PREVENTION
EP3370748A4 (en) THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND / OR PREVENTION OF FOOD ALLERGY
EP3463304A4 (en) COMPOSITIONS WITH CANNABIDIOL AND HYALURONIC ACID FOR THE TREATMENT OF INFLAMMABLE JOINT DISEASES
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
FR3011467B1 (fr) Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies
EP3341001A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT AND PROPHYLAXIS OF DARMINFECTION AND IGNITION
EP3448421A4 (en) METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING SURGICAL ADHESIVES
EP3731846A4 (en) DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF INFECTION
EP3324944A4 (en) INTRAVITREAL AGGREGATION SYSTEMS FOR THE TREATMENT OF EYE DISEASE
EP3766497A4 (en) Drug for treating cough
EP3347096A4 (en) STICK OXIDE INHALATION THERAPY FOR SMALL CHILDREN WITH BRONCHIOLITIS
MA45226A (fr) Compositions et méthodes de traitement ou de prévention d'affections liées à l'oxalate
MA42985A (fr) Traitement de troubles liés à l'acide biliaire
EP3716966A4 (en) ALPHA-KETO ACID COMPOSITIONS FOR THE TREATMENT OF HYPOALBUMINEMIA
EP3347032A4 (en) TREATMENT OF ASZITES
EP3632431A4 (en) AGENTS FOR PREVENTING OR TREATING BRAIN ATROPHY
EP2962693A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF CANCER
EP3533451A4 (en) USE OF PAEONIFLORIN-6'-O-BENZENE SULFONATE IN MEDICINE FOR TREATING SJÖGREN SYNDROME
EP3827831A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
EP3398614A4 (en) AGENTS FOR PREVENTION AND / OR TREATMENT OF MORBUS ALZHEIMER
EP3632430A4 (en) AGENTS FOR THE PREVENTION OR TREATMENT OF SPINOCERBELLARY ATAXIA
EP3518951A4 (en) COMPOSITIONS AND METHODS FOR TREATING ORTHOPEDIC COMPLAINTS
EP3302529A4 (en) COMPOSITIONS AND METHODS FOR TREATING GALLENA GANGATRESIA IN NEWBORNS